ABS Takes Smart Class Services Mobile
20.7.2020 18:00:00 EEST | Business Wire | Press release
ABS today launches a unique suite of fleet management and vessel compliance services powered by smart functionality and advanced analytics which, in an industry first, will also be available through the new ABS App.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200720005501/en/
ABS MyFreedom - Now It All Clicks (Graphic: Business Wire)
Designed to anticipate client needs and provide intuitive, informed decision support, the smart functionality is an enhancement to the ABS MyFreedom™ client portal and can be accessed through a mobile app or text. The portal and the industry’s most user-friendly digital tools simplify access to operational, technical and compliance fleet intelligence and all ABS Class services to manage the operating health and performance of fleets.
New industry-leading smart functionality launched today includes:
- The ABS Smart Scheduler™ , which leverages real-time AIS data to maintain fleet compliance and is the industry’s only mobile survey booking tool enabling any survey, including remote surveys, to be scheduled in less than a minute anytime, anywhere – even when there is no internet access. It tracks survey status for all vessels in a fleet and then issues alerts when surveys are due.
- Custom Checklist, which brings together port state data from all ABS-classed vessels to provide a port-specific checklist for crew and fleet managers prior to arrival at any port.
- Fee Estimator, which provides a comparison of estimated survey fees across multiple ports.
- Port State Control Risk, which provides customized port state control analytics by vessel or fleet. It allows clients to view their destination’s top deficiency items and the client vessel’s matching findings from ABS class records, along with a vessel risk rating based on compliance health status.
- International Safety Management (ISM) Findings, customized to individual vessel performance, which allows clients to view the destination port’s top ISM related deficiency items against their vessel’s matching findings from ABS class records.
- Port-Specific External Specialists, which provides one-touch direct client connections for upcoming surveys.
“Leveraging unprecedented access to data, we are delivering truly smart functionality that learns from the user and, with experience over time, anticipates future requirements, making it even easier to work with ABS,” said Christopher J. Wiernicki, ABS Chairman, President and CEO. “These are just the first of many enhancements and increased smart functionality that ABS will continue to deliver through the MyFreedom client portal. The portal brings together all of our clients’ Class needs digitally for a complete overview, so now it all clicks. Centralized and connected, it streamlines interactions with ABS, making our client experience straightforward and insightful.”
Offering enhanced risk management, compliance and operational efficiency through better informed decision making, MyFreedom delivers total fleet oversight, real-time survey status, smart scheduling, remote survey options, including annual surveys with mobile capture and collaboration, simplified access to compliance data and timely fleet certification renewals.
Visit our website for more information.
The ABS App is now available from the Apple App Store and Google Play.
▬▬
About ABS
ABS, a leading global provider of classification and technical advisory services to the marine and offshore industries, is committed to setting standards for safety and excellence in design and construction. Focused on safe and practical application of advanced technologies and digital solutions, ABS works with industry and clients to develop accurate and cost-effective compliance, optimized performance and operational efficiency for marine and offshore assets.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200720005501/en/
Contact information
Gareth Lewis
ABS
Global Media Relations Manager
Tel: +44 (0)20 7377 4514
Mob: +44 (0)7824 374395
Email: glewis@eagle.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM Secures €50M Financing to Accelerate Global Growth30.3.2026 09:00:00 EEST | Press release
IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), today announced it has secured a €50 millionfinancing package from funds and accounts managed by BlackRock. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329996942/en/ IQM Radiance quantum computer is located in IQM's showroom in Espoo, Finland. This facility will support acceleration of IQM’s technology roadmap, fuel R&D, support entry into additional markets, and advance IQM’s leadership in quantum computing. This facility was secured prior to IQM’s recent announcement of plans to become the first publicly listed European quantum computing company through a merger with Real Asset Acquisition Corp (“RAAQ”). The facility lowers IQM’s overall cost of capital and improves the flexibility and diversity of its capital base. “The financing package comes at a pivotal time for IQM, as we build momen
Bureau Veritas and Trade Technologies Join Forces to Streamline Global Trade Operations30.3.2026 08:45:00 EEST | Press release
Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), through its Swiss branch Government Services Division, is pleased to announce a strategic agreement with Trade Technologies, the leading provider of trade finance automation, connectivity and transaction management services. This collaboration is a significant step toward reducing the complexities of international trade operations, particularly in regions where regulatory and inspection controls remain stringent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329411683/en/ Addressing Critical Trade Finance Challenges The agreement comes at a pivotal time for global trade. Letters of Credit (LCs) continue to serve as essential instruments in international commerce, particularly across the Middle East and Africa, where counterparty risk, foreign exchange controls, sanctions exposure, and regulatory oversight face ongoing challenges. In
Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 02:35:00 EEST | Press release
Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Capability of Next Generation Earth Observation Satellites Project Title: Source-Specific CO2 Emission and Uptake Monitoring through Satellite Constellation and Ai
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release
Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom